<DOC>
	<DOCNO>NCT01399515</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety oral valproic acid slow progression visual function and/or improve visual function patient retinitis pigmentosa ( RP ) . Enrolled subject valproic acid group treat oral valproic acid 500mg daily 48 week . Visual function safety ass treatment ( 48 week ) valproic acid control group .</brief_summary>
	<brief_title>Efficacy Safety Oral Valproic Acid Retinitis Pigmentosa</brief_title>
	<detailed_description>This study design single-site , interventional , prospective , non-randomized , control study 200 participant . Patients participate study assign either valproic acid group control 3:1 ratio .</detailed_description>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Retinal Degeneration</mesh_term>
	<mesh_term>Genetic Diseases , Inborn</mesh_term>
	<mesh_term>Eye Diseases , Hereditary</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Diagnosis retinitis pigmentosa ( RP ) establish night blindness , visual field constriction , mark reduction electroretinogram , clinical sign RP fundus examination Best correct visual acuity 20/200 Snellen chart least one eye Intact visual field 5 measure kinetic perimetry Understand sign IRBapproved inform consent document study Body weight : male ( 40 kg 100 kg ) , female ( 40 kg 80 kg ) Must able swallow tablet Female subject childbearing potential must commit practice acceptable method contraception Pregnant woman Lactating mother Medical problem make consistent followup treatment period unlikely ( e.g. , stroke , myocardiac infarction , malignancy ) severe systemic disease Other ocular disease : retinal disease RP cystoid macular edema , glaucoma , cataract bad +2PSC infectious corneal disease Coagulation disorder bleedingtendency Liver dysfunction Renal dysfunction History pancreatitis History neurological disorder include epilepsy , history brain injury organic brain disorder History mental disorder include schizophrenia , bipolar disorder , suicidality Currently receive valproic acid anticonvulsant Has take one follow drug least 4 week prior enrollment drug specifically know affect progression RP : vitamin A , lutein , omega3 fatty acid , antioxidant affect blood flow retina retinal function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Retinitis pigmentosa</keyword>
	<keyword>Valproic acid</keyword>
</DOC>